This session will explore the intricate relationship between gut microbiota and various metabolic disorders, including obesity and diabetes. Emphasis will be placed on clinical research findings that elucidate microbial influences on metabolic pathways.

This track focuses on the latest advancements in molecular diagnostics that aid in the assessment of metabolic health. Participants will discuss innovative biomarkers and their potential applications in clinical settings.

This session aims to bridge the gap between basic research and clinical application in the field of metabolism and gut microbiome. Presentations will highlight successful translational strategies that have led to improved patient outcomes.

This track will delve into emerging therapeutic strategies that target the gut microbiome to enhance metabolic health. Discussions will include pharmacological interventions, dietary modifications, and probiotics.

Participants will explore cutting-edge laboratory techniques used in metabolomics research, including mass spectrometry and nuclear magnetic resonance. The focus will be on how these techniques can advance our understanding of metabolism.

This session will address the use of disease models to study metabolic pathways and their dysregulation. Researchers will present findings that demonstrate how these models can inform therapeutic development.